| Literature DB >> 32389373 |
Y Lu1, H Wen1, D Rong2, Z Zhou1, H Liu3.
Abstract
AIM: To identify and summarise the common findings from 2019 novel coronavirus (2019-nCoV) infections in children.Entities:
Mesh:
Year: 2020 PMID: 32389373 PMCID: PMC7252054 DOI: 10.1016/j.crad.2020.04.010
Source DB: PubMed Journal: Clin Radiol ISSN: 0009-9260 Impact factor: 2.350
Clinical characteristic of nine children infected with 2019-nCoV.
| Case no. | Sex | Age (year) | Initial diagnosis | Epidemiology history | WBC count (×109/l) | Lymphocyte count (×109/l) | 2019-nCov nucleic acid real-time PCR test | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Temp (°C) | Symptoms | Exposure history | Close contact history | Familial cluster | Incubation period (day) | Oropharyngeal swab | Cloacal swab | Urine | |||||
| 1 | Male | 13 | 36.8° | None | - | + | + | - | 5.9 | 2.03 | + | - | - |
| 2 | Female | 7 | 38.7° | Fever | + | -/+ | + | 2–14 | 5.7 | 2.34 | + | + | + |
| 3 | Male | 1 | 37.8° | Fever | + | + | + | 9 | 7.8 | 6.19 | + | + | - |
| 4 | Female | 12 | 38° | Fever | + | - | + | 4–10 | 3.8 | 1.26 | + | - | - |
| 5 | Male | 6 | 39.1° | Fever/cough | + | - | + | 2–8 | 12 | 1.35 | + | + | - |
| 7 | Male | 3 | 36° | Stuffy nose/post-nasal drip | - | + | + | 9 | 8.8 | 4.73 | + | + | - |
| 7 | Female | 15 | 38.5° | Fever | + | - | + | 12 | 4.0 | 1.66 | + | - | - |
| 8 | Male | 13 | 38.5° | Fever/cough | + | - | + | 9 | 7.8 | 1.75 | + | - | - |
| 9 | Female | 0.17 | 36.8° | Cough | + | + | + | >8 | 10.8 | 9.05 | + | - | - |
Clear history of exposure to epidemic area including Wuhan (three cases), Suizhou (one case), Jingzhou (two cases), Enshi (one case) cities, Hubei Province, China.
Patient had no symptoms but was living in Wuhan and visited Guangzhou with his grandfather on 20 January 2020. He was tested for 2019-nCoV by the CDC because his grandfather had confirmed 2019-nCoV infection.
Between 12–24 January 2020, the patient visited the epidemic area of Suizhou, but did not have a history of contact with suspected 2019-nCoV-infected patients. Once back in Guangzhou, the patient was exposed to a suspected infected person on a train on 24 January 2020, and had fever on 26 January 2020.
Patient was visiting the epidemic area of Jingzhou from 16–22 January 2020, and had fever on 26 January 2020.
Patient was visiting the epidemic area of Wuhan from 14–20 January 2020, and had fever and cough on 22 January 2020.
The incubation period (>8 days) of this 2-month-old patient is unclear, but was living in Wuhan, Hubei Province, and visited Guangdong Province on 25 January 2020. The patient's father had cough, weakness, and sore throat, and the patient then developed the disease as the final member of this family on 2 February 2020.
Figure 1(a) A 13-year-old asymptomatic male patient infected with the 2019-nCoV, with a history of close contact with confirmed 2019-nCoV-infected patients. The bedside radiograph indicated no obvious abnormality. (b) A 3-year-old male patient, presented with a stuffy nose and rhinorrhoea, with a history of close contact with confirmed 2019-nCoV-infected patients. Bedside radiographs indicated increased and/or disordered bilateral bronchovascular shadows and dense hilar shadows.
Chest radiography and CT image features of infected children.
| Patient no. | Radiography features | CT features |
|---|---|---|
| 1 | No clear abnormality | No overt abnormality |
| 2 | Disordered bilateral bronchovascular shadows | No overt abnormality |
| 3 | No overt abnormality | No overt abnormality |
| 4 | No overt abnormality | Parenchymal bands |
| 5 | Increased bilateral bronchovascular shadows | No overt abnormality |
| 6 | Increased and disordered bilateral bronchovascular shadows, dense hilar shadows | Multiple scattered patchy ground-glass opacities with slightly thickened vascular shadow in the centre, blurred border and “halo sign” |
| 6: follow-up | — | The lesions are well absorbed and shrank, with density reduction in the central area |
| 7 | No overt abnormality | Subpleural scattered striped ground-glass opacities with clear edge |
| 8 | No overt abnormality | Patchy mild ground-glass opacities in the upper lobe of left lung, small patchy ground-glass opacity with clear edge in the inferior lobe of right lung |
| 9 | Increased and disordered bilateral bronchovascular shadows, | Multiple scattered patchy ground-glass opacities in the subpleural or peripheral of both lungs |
| 9: follow-up | - | The patchy shadows are absorbed and shrank, with density reduction |
Ground-glass opacity: slightly high-density shadow, like ground glass; parenchymal band: a linear opacity, usually 1–3 mm thick and >2 cm in length (up to 5 cm) that usually extends to the visceral pleura (which is often thickened and may be retracted at the site of contact).
Figure 2A 13-year-old male patient with a clear exposure history to the epidemic area (Hubei Province, China) who presented with fever and cough received treatment for symptoms in the isolation unit. (a) Axial thin-section unenhanced CT image shows slight ground-glass opacity (black arrow) in the subpleural area of the left upper lobe. (b) Sagittal image shows a patchy ground-glass opacity (white arrow).
Figure 3A 3-year-old male patient with a history of close contact with a confirmed 2019-nCoV-infected patient, who presented with a stuffy nose and rhinorrhoea, received interferon-alpha atomising therapy in the isolation unit. (a) Axial unenhanced CT image (scanned on 5 February 2020) shows multiple mixed patchy shadows and ground-glass opacities, with a central thickened vascular shadow and a blurred edge, in the subpleural area of the inferior lobe in the right lung. (b) The CT image (scanned on 9 February 2020) indicates that the lesions resolved, with density reduction in the central area, in the same location in the inferior lobe in the right lung.
Figure 4A 15-year-old female patient with a history of exposure to the epidemic area, who presented with fever, received treatment for symptoms in the isolation unit. Axial unenhanced CT image shows parenchymal bands.